Researchers are making progress in the development of a biomarker for parkinsonian disorders, which could potentially lead to earlier detection of the disease. A blood test for parkinson's disease may be in the works, with several institutions and studies contributing to the search for a reliable biomarker. The effort to identify a biomarker is part of a broader push to improve diagnosis and detection of neurodegenerative diseases, including dementia and alzheimer's.